ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2019
Neurological presentations of Bartonella henselae infection.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Experimental Infection of Ferrets withPathogens (Basel, Switzerland) · 2025Article
- A One Health Zoonotic Vector Borne Infectious Disease Family Outbreak Investigation.Pathogens (Basel, Switzerland) · 2025Article
- A case of isolated meningitis caused byIDCases · 2025Article
- Neurobartonelloses: emerging from obscurity!Parasites & vectors · 2024Review
- Human Babesia odocoilei and Bartonella spp. co-infections in the Americas.Parasites & vectors · 2024Article
- Vector biology of the cat flea Ctenocephalides felis.Trends in parasitology · 2024Review
- Vague Presentation of Cat Scratch Disease in a Child.Ochsner journal · 2024Article
- Article
- Article
- Article
- Blood Supplementation Enhances Bartonella henselae Growth and Molecular Detection of Bacterial DNA in Liquid Culture.Microbiology spectrum · 2023Article
- Complete Remission in Paralytic Late Tick-Borne Neurological Disease Comprising Mixed Involvement ofAntibiotics (Basel, Switzerland) · 2023Article
- From (Cat) Scratch: A Unique Presentation of Central Nervous System Bartonella Infection.Cureus · 2023Article
- The association of host and vector characteristics withFrontiers in microbiology · 2023Article
- Article
- The Clinical Profile of Cat-Scratch Disease's Neuro-Ophthalmological Effects.Brain sciences · 2022Review
- Development of a Multiplex Droplet Digital PCR Assay for the Detection ofPathogens (Basel, Switzerland) · 2021Article
- Bartonella spp. seroprevalence in tick-exposed Swedish patients with persistent symptoms.Parasites & vectors · 2021Article
- Cerebral epidural empyema due to Bartonella henselae: a case report.BMC infectious diseases · 2021Article
- Schizophrenia andVector borne and zoonotic diseases (Larchmont, N.Y.) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveNeurological symptoms in patients with cat-scratch disease (CSD) have been rarely reported. The aim of this study is to analyze the frequency of neurological CSD (NCSD) and describe the disease clinical presentation, management and outcome. MATERIAL AND
methodsWe retrospectively selected patients with a CSD syndrome and Bartonella IgG titers > 1:256. Data regarding epidemiological, clinical, management, and follow-up features were analyzed and discussed. A comparison between NCSD and non-neurological CSD (NNCSD) was established.
resultsThirty-nine CSD patients were selected. NCSD frequency was 10.25%. No children were found affected in the NCSD group. A 65.7% of NNCSD and the entirety of the NCSD group had a history of cat exposure. Immunosuppression was only present in the NNCSD group (8.6%). NCSD presentations were as follows: isolated aseptic meningitis (25%), neuroretinitis (50%), and isolated optic neuritis (25%). A greater proportion of patients in the NCSD group had fever and raised levels of acute phase reactants and white blood cells. 85.7% of NNCSD had a complete recovery, whereas only 50% of the NCSD patients experienced a full recovery.
conclusionNCSD may be a distinctive group compared to NNCSD due to its later age of presentation, the more intense systemic response, and the poorer outcome.
Indexed as
Identifiers
30368695What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.